Anti-transferrin receptor 1 antibody reduces angiotensin II-induced vascular remodeling
- PMID: 40409405
- DOI: 10.1016/j.yjmcc.2025.05.006
Anti-transferrin receptor 1 antibody reduces angiotensin II-induced vascular remodeling
Abstract
Aortic abundance of transferrin receptor 1 (TfR1), a cellular iron receptor, is increased in several vascular diseases; however, the effects of anti-TfR1 antibody on vascular diseases remains largely unknown. Herein, we investigated our hypothesis that anti-TfR1 antibody can attenuate vascular remodeling. Mice were infused with angiotensin II (AngII) to induce vascular remodeling with or without anti-TfR1 antibody. Notably, anti-TfR1 antibody attenuated vascular remodeling in mice with AngII infusion. Moreover, anti-TfR1 antibody suppressed AngII-induced proliferation and migration in cultured vascular smooth muscle cells. Thus, targeting TfR1 with an antibody may have therapeutic potential for vascular remodeling.
Keywords: Hypertension; Transferrin receptor 1; Vascular remodeling.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest T. Matsuura is a board member and chief technology officer of Perseus Proteomics Inc. and has stock options of Perseus Proteomics Inc. The authors do not have any other conflicts of interest to declare.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources